Search Results - "Rawlings-Rhea S"

Recurrent Limitations of CAR-T Therapy in Gliomas: Evidence from Preclinical and Phase I Clinical Studies.

Authors: Bria, Jessica Filardo, Andrea Di Vito, Anna et al.

Source: International Journal of Molecular Sciences. Dec2025, Vol. 26 Issue 23, p11435. 16p.

Metabolic and Post-Translational Vulnerabilities of Glioblastoma: Disulfidptosis, Glycosylation, and Implications for CAR-T Therapy.

Authors: Strózik, Tadeusz Rutkowska, Adrianna Wasiak, Tomasz et al.

Source: Cells (2073-4409). Jun2026, Vol. 15 Issue 12, p1087. 39p.

In Vivo CAR-Based Immune Cell Engineering: Future Applications and Challenges in Malignant Glioma.

Authors: Yamaguchi, Junya Bergquist, Alejandra Lu, Jianwen et al.

Source: Cancers. Jun2026, Vol. 18 Issue 12, p1986. 32p.

Investigating the Impact of Zinc Oxide Nanoparticles and Folic Acid on Neuronal Markers in a Rat Model of Nanotoxicity.

Authors: Nusair, Shreen Deeb Almbaidin, Rand Ghaleb Al-Sawalha, Nour Ahmad et al.

Source: Journal of Toxicology. 9/23/2025, Vol. 2025, p1-8. 8p.

Differential susceptibility and role for senescence in CART cells based on costimulatory domains.

Authors: Can, Ismail Siegler, Elizabeth L. Sirpilla, Olivia L. et al.

Source: Molecular Cancer. 6/10/2025, Vol. 24 Issue 1, p1-16. 16p.

Heat up and Destroy: Immunotherapy of "Cold" Tumors Using the Example of Glioblastoma.

Authors: Nikitina, Yuliya Kazakova, Alina Bogachek, Maria et al.

Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 5, p2457. 50p.

Targeting stromal cells in tumor microenvironment as a novel treatment strategy for glioma.

Authors: Geng, Ziang Zhang, Zheyuan Wang, Miaohan et al.

Source: Cancer Cell International. 2/21/2025, Vol. 25 Issue 1, p1-16. 16p.

A Novel MICB-Targeting CAR-NK Cells for the Treatment of Pancreatic Cancer.

Authors: Jin, Weiyang Wang, Mengying Wang, Jingwei et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 1, p500. 16p.

Timely Leukapheresis May Interfere with the "Fitness" of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients.

Authors: Farina, Mirko Chiarini, Marco Almici, Camillo et al.

Source: Cancers. Nov2022, Vol. 14 Issue 21, p5276. 14p.

Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular Immunotherapy.

Authors: Abdel-Azim H Dave H Jordan K et al.

Source: Cytotherapy [Cytotherapy] 2022 Feb; Vol. 24 (2), pp. 193-204. Date of Electronic Publication: 2021 Oct 26.

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE

From Bench to Bedside: Emerging Paradigms in CAR‐T Cell Therapy for Solid Malignancies.

Authors: Chen, Yang Ren, Ran Yan, Lirong et al.

Source: Advanced Science. 10/27/2025, Vol. 12 Issue 40, p1-24. 24p.

Advancing CAR T-Cell Therapy in Solid Tumors: Current Landscape and Future Directions.

Authors: Rafii, Saeed Mukherji, Deborah Komaranchath, Ashok Sebastian et al.

Source: Cancers. Sep2025, Vol. 17 Issue 17, p2898. 52p.

Advancing Medulloblastoma Therapy in Pediatrics: Integrative Molecular Classification and Emerging Treatments.

Authors: Kim, David T. Uloho-Okundaye, Michaela Frederico, Stephen C. et al.

Source: Brain Sciences (2076-3425). Aug2025, Vol. 15 Issue 8, p896. 23p.

Unraveling resistance mechanisms in anti-CD19 chimeric antigen receptor-T therapy for B-ALL: a novel in vitro model and insights into target antigen dynamics.

Authors: Li, Hongzhe Wang, Yuwen Liu, Rongrong et al.

Source: Journal of Translational Medicine. 5/21/2024, Vol. 22 Issue 1, p1-15. 15p.

Genome-wide profiling of retroviral DNA integration and its effect on clinical pre-infusion CAR T-cell products.

Authors: Shao, Lipei Shi, Rongye Zhao, Yingdong et al.

Source: Journal of Translational Medicine. 11/8/2022, Vol. 20 Issue 1, p1-15. 15p.

Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon.

Authors: Martino, Massimo Naso, Virginia Loteta, Barbara et al.

Source: International Journal of Molecular Sciences. Nov2022, Vol. 23 Issue 21, p13332. 10p.

Transcriptional and functional profiling reveals unique activation of Adapter CAR T cells in acute myeloid leukemia.

Authors: Knelangen N Bader U Maniaki E et al.

Source: Journal of translational medicine [J Transl Med] 2026 Jun 18; Vol. 24 (1). Date of Electronic Publication: 2026 Jun 18.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

Characterizing the exposure–response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma.

Authors: Connarn, Jamie N. Witjes, Han van Zutphen‐van Geffen, Marielle et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Nov2023, Vol. 12 Issue 11, p1687-1697. 11p.

Exploring CAR-T Cell Therapy Side Effects: Mechanisms and Management Strategies.

Authors: Zhang, Yugu Qin, Diyuan Shou, Arthur Churchill et al.

Source: Journal of Clinical Medicine. Oct2023, Vol. 12 Issue 19, p6124. 16p.

Recurrent Glioblastoma: A Review of the Treatment Options.

Authors: Vaz-Salgado, Maria Angeles Villamayor, María Albarrán, Víctor et al.

Source: Cancers. Sep2023, Vol. 15 Issue 17, p4279. 22p.